Fig. 4From: Impact of rewarming rate on interleukin-6 levels in patients with shockable cardiac arrest receiving targeted temperature management at 33 °C: the ISOCRATE pilot randomized controlled trialDistribution of Cerebral Performance Category scores in each groupBack to article page